For press inquiries click here to contact us.
Avenzo Therapeutics
Avenzo and Gilead partner for breast cancer combination regimen trial
Element Biosciences
Element Biosciences nets $277M ahead of new sequencer launch
Kinnate Biopharma
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
Xaira Therapeutics
Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D
Alumis, Inc.
Alumis closes $259M series C in year’s largest private biotech fundraise yet
Thyme Care
This Startup Just Raised $60 Million To Help Cancer Patients Navigate Their Care
CG Oncology
CG Oncology reels in $105M crossover for potential late 2024 bladder cancer drug filing
Everly Health
Scoop: Everly partnership to offer home cancer tests to health plan
Remix Therapeutics
Is there room for a new way to drug RNA? ARCH, Foresite join Atlas, The Column Group for $81M bet
Please see important disclaimers in the Terms section.
